IDEXX Laboratories Inc
IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$676.21−13.44 (-1.95%)
Close on Nov 20, 2026Market cap $53.27BP/E 47.6Yield –
IDEXX Laboratories Inventory Breakdown by Production Stage
Inventory Breakdown by Production Stage ($M)
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Inventory Breakdown by Production Stage ($M) | Year on year | Source |
|---|
Breakdown
What makes up inventory Breakdown by Production Stage
Cite this data
StockData. (2026). IDEXX Laboratories Inventory Breakdown by Production Stage ($M), quarterly [Data set]. Compiled from IDEXX Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/idxx/kpis/inv-breakdown-header
See every metric in the IDEXX Laboratories KPI table. Data updated Nov 7, 2026.
See a number that looks wrong?